← Back
$APGE All transactions

Apogee Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$677K

Shares

8,476

Price

$80

Filed

Jan 16

Insider

Name

HENDERSON MICHAEL THOMAS

Title

Chief Executive Officer

CIK

0001779990

Roles

Director Officer

Transaction Details

Transaction Date

2026-01-14

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,203,071

Footnotes

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2025. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.16 to $79.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $79.28 to $80.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $80.69 to $81.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.70 to $82.69, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $82.71 to $83.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $83.73 to $83.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

Filing Info

Accession No.

0001104659-26-004659

Form Type

4

Issuer CIK

0001974640

HENDERSON MICHAEL THOMAS's History

Date Ticker Type Value
2026-04-16 APGE M $69K
2026-04-16 APGE M $0
2026-04-08 APGE $1.5M
2026-04-08 APGE $167K
2026-04-08 APGE $17K
2026-01-21 SYRE J $0
2026-01-14 APGE $113K
2026-01-14 APGE $677K
2026-01-14 APGE $192K
2026-01-14 APGE $153K

Other Insiders at APGE (90d)

Insider Bought Sold Last
Henderson Jane
Chief Financial Officer
$652K 2026-04-16
HENDERSON MICHAEL THOMAS
Chief Executive Officer
$1.7M 2026-04-16
Dambkowski Carl
Chief Medical Officer
$828K 2026-04-01